Menu
Recruiting NCT05981482

Visual Perception Difficulties After Stroke

Observational Stroke Visual Perception

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: OxVPS.
Who it may be relevant to
Registry conditions: Stroke, Visual Perception. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Accuracy and Utility of the Oxford Visual Perception Screening (OxVPS), a Screening for Visual Perception Difficulties in Stroke Survivors

Overview

The goal of this observational study is to learn how well the Oxford Visual Perception Screening (OxVPS) tool can identify stroke survivors with visual perception difficulties. The main aim is to determine the accuracy and utility of the OxVPS compared to the current gold standard assessment in stroke survivors. In other words, how well can the Oxford Visual Perception Screening tool (OxVPS) identify stroke patients with visual perception problems? Participants will completed the OxVPS and the current gold standards visual perception screening tool.

Detailed description

This is a non-experimental cross-sectional study. It aims to compare the new screening test OxVPS to the gold standard tests for visual perception difficulties.

Patients will be recruited at stroke rehabilitation units at hospitals in the North East of England and in Oxfordshire.

Following consent:

* Participants will complete the paper version of the Oxford Visual Perception Screen OxVPS (\~15 min). * Participants will complete screening for visual perception problems with a validated screening tool (\~30-120 min). * Participants will complete screening for cognition alterations and sensory vision with validated screening tools. (\~30 min) * Stroke details (time since stroke, severity) and demographic data (age, socio-economic status) will be collected to evaluated representativeness of the sample.

Interventions

  • Diagnostic test OxVPS
    Comparing a new screening tool, the Oxford visual perception screening, to the gold standard, Rivermead Perceptual Battery Assessment.

Primary outcome measures

  • Validity of OxVPS [Time frame: All testing completed in 2 weeks]
  • Reliability of OxVPS [Time frame: 2 weeks]

Eligibility criteria

Inclusion criteria

  • Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage).
  • Within 6 weeks of confirmed stroke.

Exclusion criteria

  • Insufficient understanding of English
  • Clinical concerns that patient is unable follow simple instructions.
  • Clinical concerns that patient is unable to concentrate for 15 minutes.
  • No capacity to provide informed consent.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United Kingdom · 3 centers
  • Abingdon Community Hospital — Abingdon
  • Bishop Auckland Hospital — Bishop Auckland
  • Queen Elizabeth Hospital — Gateshead

Identifiers

NCT: NCT05981482 · Durham University

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗